|
1
|
Zhang P, Li S, Zhang T, Cui F, Shi JH,
Zhao F and Sheng X: Characterization of molecular subtypes in head
and neck squamous cell carcinoma with distinct prognosis and
treatment responsiveness. Front Cell Dev Biol. 9:7113482021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alsahafi E, Begg K, Amelio I, Raulf N,
Lucarelli P, Sauter T and Tavassoli M: Clinical update on head and
neck cancer: Molecular biology and ongoing challenges. Cell Death
Dis. 10:5402019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Canning M, Guo G, Yu M, Myint C, Groves
MW, Byrd JK and Cui Y: Heterogeneity of the head and neck squamous
cell carcinoma immune landscape and its impact on immunotherapy.
Front Cell Dev Biol. 7:522019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Whiteside TL: The effect of tumor-derived
exosomes on immune regulation and cancer immunotherapy. Future
Oncol. 13:2583–2592. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Whiteside TL: Exosomes carrying
immunoinhibitory proteins and their role in cancer. Clin Exp
Immunol. 189:259–267. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Whiteside TL: Exosomes in cancer: Another
mechanism of tumor-induced immune suppression. Adv Exp Med Biol.
1036:81–89. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Milane L, Singh A, Mattheolabakis G,
Suresh M and Amiji MM: Exosome mediated communication within the
tumor microenvironment. J Control Release. 219:278–294. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hofmann L, Ludwig S, Schuler PJ, Hoffmann
TK, Brunner C and Theodoraki MN: The potential of CD16 on
plasma-derived exosomes as a liquid biomarker in head and neck
cancer. Int J Mol Sci. 21:37392020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Barros-Martins J, Bruni E, Fichtner AS,
Cornberg M and Prinz I: OMIP-084: 28-Color full spectrum flow
cytometry panel for the comprehensive analysis of human γδ T cells.
Cytometry A. 101:856–861. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ziegler-Heitbrock L: Blood monocytes and
their subsets: Established features and open questions. Front
Immunol. 6:4232015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Idel C, Loyal K, Rades D, Hakim SG,
Schumacher U, Bruchhage KL and Pries R: Smoking-, alcohol-, and
age-related alterations of blood monocyte subsets and circulating
CD4/CD8 T cells in head and neck cancer. Biology (Basel).
11:6582022.PubMed/NCBI
|
|
12
|
Wong KL, Yeap WH, Tai JJ, Ong SM, Dang TM
and Wong SC: The three human monocyte subsets: Implications for
health and disease. Immunol Res. 53:41–57. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Patel AA, Zhang Y, Fullerton JN, Boelen L,
Rongvaux A, Maini AA, Bigley V, Flavell RA, Gilroy DW, Asquith B,
et al: The fate and lifespan of human monocyte subsets in steady
state and systemic inflammation. J Exp Med. 214:1913–1923. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Boyette LB, Macedo C, Hadi K, Elinoff BD,
Walters JT, Ramaswami B, Chalasani G, Taboas JM, Lakkis FG and
Metes DM: Phenotype, function, and differentiation potential of
human monocyte subsets. PLoS One. 12:e01764602017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jakubzick CV, Randolph GJ and Henson PM:
Monocyte differentiation and antigen-presenting functions. Nat Rev
Immunol. 17:349–362. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rossol M, Kraus S, Pierer M, Baerwald C
and Wagner U: The CD14(bright) CD16+ monocyte subset is expanded in
rheumatoid arthritis and promotes expansion of the Th17 cell
population. Arthritis Rheum. 64:671–677. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Moniuszko M, Bodzenta-Lukaszyk A, Kowal K,
Lenczewska D and Dabrowska M: Enhanced frequencies of CD14++CD16+,
but not CD14+CD16+, peripheral blood monocytes in severe asthmatic
patients. Clin Immunol. 130:338–346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Azeredo EL, Neves-Souza PC, Alvarenga AR,
Reis SR, Torrentes-Carvalho A, Zagne SM, Nogueira RM,
Oliveira-Pinto LM and Kubelka CF: Differential regulation of
toll-like receptor-2, toll-like receptor-4, CD16 and human
leucocyte antigen-DR on peripheral blood monocytes during mild and
severe dengue fever. Immunology. 130:202–216. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Subimerb C, Pinlaor S, Khuntikeo N,
Leelayuwat C, Morris A, McGrath MS and Wongkham S: Tissue invasive
macrophage density is correlated with prognosis in
cholangiocarcinoma. Mol Med Rep. 3:597–605. 2010.PubMed/NCBI
|
|
20
|
Schauer D, Starlinger P, Reiter C, Jahn N,
Zajc P, Buchberger E, Bachleitner-Hofmann T, Bergmann M, Stift A,
Gruenberger T and Brostjan C: Intermediate monocytes but not
TIE2-expressing monocytes are a sensitive diagnostic indicator for
colorectal cancer. PLoS One. 7:e444502012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang H, Zhou L, Shen N, Ning X, Wu D,
Jiang K and Huang X: M1 macrophage-derived exosomes and their key
molecule lncRNA HOTTIP suppress head and neck squamous cell
carcinoma progression by upregulating the TLR5/NF-κB pathway. Cell
Death Dis. 13:1832022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hong CS, Funk S, Muller L, Boyiadzis M and
Whiteside TL: Isolation of biologically active and morphologically
intact exosomes from plasma of patients with cancer. J Extracell
Vesicles. 5:292892016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Théry C, Witwer KW, Aikawa E, Alcaraz MJ,
Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F,
Atkin-Smith GK, et al: Minimal information for studies of
extracellular vesicles 2018 (MISEV2018): A position statement of
the international society for extracellular vesicles and update of
the MISEV2014 guidelines. J Extracell Vesicles. 7:15357502018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Theodoraki MN, Matsumoto A, Beccard I,
Hoffmann TK and Whiteside TL: CD44v3 protein-carrying tumor-derived
exosomes in HNSCC patients' plasma as potential noninvasive
biomarkers of disease activity. Oncoimmunology. 9:17477322020.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Theodoraki MN, Hoffmann TK and Whiteside
TL: Separation of plasma-derived exosomes into CD3(+) and CD3(−)
fractions allows for association of immune cell and tumour cell
markers with disease activity in HNSCC patients. Clin Exp Immunol.
192:271–283. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Polasky C, Steffen A, Loyal K, Lange C,
Bruchhage KL and Pries R: Reconstitution of monocyte subsets and
PD-L1 expression but Not T cell PD-1 expression in obstructive
sleep apnea patients upon PAP therapy. Int J Mol Sci. 22:113752021.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Polasky C, Steffen A, Loyal K, Lange C,
Bruchhage KL and Pries R: Redistribution of monocyte subsets in
obstructive sleep apnea syndrome patients leads to an imbalanced
PD-1/PD-L1 cross-talk with CD4/CD8 T cells. J Immunol. 206:51–58.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sakakura K, Takahashi H, Motegi SI,
Yokobori-Kuwabara Y, Oyama T and Chikamatsu K: Immunological
features of circulating monocyte subsets in patients with squamous
cell carcinoma of the head and neck. Clin Immunol. 225:1086772021.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takahashi H, Sakakura K, Tada H, Kaira K,
Oyama T and Chikamatsu K: Prognostic significance and population
dynamics of peripheral monocytes in patients with oropharyngeal
squamous cell carcinoma. Head Neck. 41:1880–1888. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Subimerb C, Pinlaor S, Lulitanond V,
Khuntikeo N, Okada S, McGrath MS and Wongkham S: Circulating
CD14(+) CD16(+) monocyte levels predict tissue invasive character
of cholangiocarcinoma. Clin Exp Immunol. 161:471–479. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Theodoraki MN, Laban S, Jackson EK, Lotfi
R, Schuler PJ, Brunner C, Hoffmann TK, Whiteside TL and Hofmann L:
Changes in circulating exosome molecular profiles following
surgery/(chemo)radiotherapy: Early detection of response in head
and neck cancer patients. Br J Cancer. 125:1677–1686. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ludwig S, Floros T, Theodoraki MN, Hong
CS, Jackson EK, Lang S and Whiteside TL: Suppression of lymphocyte
functions by plasma exosomes correlates with disease activity in
patients with head and neck cancer. Clin Cancer Res. 23:4843–4854.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yoshioka Y, Konishi Y, Kosaka N, Katsuda
T, Kato T and Ochiya T: Comparative marker analysis of
extracellular vesicles in different human cancer types. J Extracell
Vesicles. 2:2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hofmann L, Abou Kors T, Ezić J, Niesler B,
Röth R, Ludwig S, Laban S, Schuler PJ, Hoffmann TK, Brunner C, et
al: Comparison of plasma- and saliva-derived exosomal miRNA
profiles reveals diagnostic potential in head and neck cancer.
Front Cell Dev Biol. 10:9715962022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bose A, Chakraborty T, Chakraborty K, Pal
S and Baral R: Dysregulation in immune functions is reflected in
tumor cell cytotoxicity by peripheral blood mononuclear cells from
head and neck squamous cell carcinoma patients. Cancer Immun.
8:102008.PubMed/NCBI
|
|
36
|
Türkseven MR and Oygür T: Evaluation of
natural killer cell defense in oral squamous cell carcinoma. Oral
Oncol. 46:e34–e37. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Watanabe M, Kono K, Kawaguchi Y, Mizukami
Y, Mimura K, Maruyama T, Izawa S and Fujii H: NK cell dysfunction
with down-regulated CD16 and up-regulated CD56 molecules in
patients with esophageal squamous cell carcinoma. Dis Esophagus.
23:675–681. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dasgupta S, Bhattacharya-Chatterjee M,
O'Malley BW Jr and Chatterjee SK: Inhibition of NK cell activity
through TGF-beta 1 by down-regulation of NKG2D in a murine model of
head and neck cancer. J Immunol. 175:5541–5550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ou Z, Dolmatova E, Lassègue B and
Griendling KK: β1- and β2-integrins: Central players in regulating
vascular permeability and leukocyte recruitment during acute
inflammation. Am J Physiol Heart Circ Physiol. 320:H734–H739. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang C, Ou R, Chen X, Zhang Y, Li J,
Liang Y, Zhu X, Liu L, Li M, Lin D, et al: Tumor cell-derived SPON2
promotes M2-polarized tumor-associated macrophage infiltration and
cancer progression by activating PYK2 in CRC. J Exp Clin Cancer
Res. 40:3042021. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Auffray C, Fogg D, Garfa M, Elain G,
Join-Lambert O, Kayal S, Sarnacki S, Cumano A, Lauvau G and
Geissmann F: Monitoring of blood vessels and tissues by a
population of monocytes with patrolling behavior. Science.
317:666–670. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
McDermott DH, Halcox JP, Schenke WH,
Waclawiw MA, Merrell MN, Epstein N, Quyyumi AA and Murphy PM:
Association between polymorphism in the chemokine receptor CX3CR1
and coronary vascular endothelial dysfunction and atherosclerosis.
Circ Res. 89:401–407. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tacke F, Alvarez D, Kaplan TJ, Jakubzick
C, Spanbroek R, Llodra J, Garin A, Liu J, Mack M, van Rooijen N, et
al: Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1
to accumulate within atherosclerotic plaques. J Clin Invest.
117:185–194. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ishida Y, Kuninaka Y, Yamamoto Y, Nosaka
M, Kimura A, Furukawa F, Mukaida N and Kondo T: Pivotal involvement
of the CX3CL1-CX3CR1 axis for the recruitment of M2
tumor-associated macrophages in skin carcinogenesis. J Invest
Dermatol. 140:1951–1961.e6. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Freeman GJ, Long AJ, Iwai Y, Bourque K,
Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne
MC, et al: Engagement of the PD-1 immunoinhibitory receptor by a
novel B7 family member leads to negative regulation of lymphocyte
activation. J Exp Med. 192:1027–1034. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Logozzi M, Mizzoni D, Di Raimo R, Giuliani
A, Maggi M, Sciarra A and Fais S: Plasmatic exosome number and size
distinguish prostate cancer patients from healthy individuals: A
prospective clinical study. Front Oncol. 11:7273172021. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Logozzi M, Mizzoni D, Angelini DF, Di
Raimo R, Falchi M, Battistini L and Fais S: Microenvironmental pH
and exosome levels interplay in human cancer cell lines of
different histotypes. Cancers (Basel). 10:3702018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Logozzi M, De Milito A, Lugini L, Borghi
M, Calabrò L, Spada M, Perdicchio M, Marino ML, Federici C, Iessi
E, et al: High levels of exosomes expressing CD63 and caveolin-1 in
plasma of melanoma patients. PLoS One. 4:e52192009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Rodríguez Zorrilla S, Pérez-Sayans M, Fais
S, Logozzi M, Gallas Torreira M and García García A: A pilot
clinical study on the prognostic relevance of plasmatic exosomes
levels in oral squamous cell carcinoma patients. Cancers (Basel).
11:4292019. View Article : Google Scholar : PubMed/NCBI
|
